MedPath

MYLAN-AMILAZIDE

MYLAN-AMILAZIDE

Discontinued
DIN Number

02257378

Drug Class

Human

Market Date

Sep 8, 2005

Company
HC

Mylan Pharmaceuticals ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02257378
AIG Number0213868001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03EA01 HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.16
Health Canada Classification

ACTIVE INGREDIENTS (2)

AMILORIDE HYDROCHLORIDEActive
Strength: 5 MG
Monograph: AMILORIDE HYDROCHLORIDE
HYDROCHLOROTHIAZIDEActive
Strength: 50 MG
Monograph: HYDROCHLOROTHIAZIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.